| abstract |
The present invention relates to compounds of formula (I), wherein A is a group of (a) or (b) and their salts or solvates, the compositions pharmaceutical containing, a process for their preparation and intermediates in this procécé. Compounds Formula (I) may be indicated in the treatment of gastrointestinal diseases. intestinal Inflammatory bowel diseases such as colon syndromes irritable (IBD), as modulators of intestinal motility, such as lipolytics, anti-inflammatory agents, obesity, anti-diabetics, psychotropic, anti-glaucomatous, healing, anti-depressant, as inhibitory heir of uterine contractions, as tocolytic to prevent or delay early deliveries, for the treatment and / or prophylaxis of dysmenorrhea. In addition compounds of formula (I) can be used in the treatment of certain diseases of the system central nervous system that for example depression, as well as some system disorders urinary urinary incontinence. (see formula I) (see formula a) or (see formula b) |